Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Cell Carcinoma × Pemetrexed × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 167 Lung Neoplasms 61 Neoplasms 21 Neoplasm Metastasis 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 13 Mesothelioma, Malignant 12 Colorectal Neoplasms 10 Carcinoma 10 Meningeal Carcinomatosis 9 Mesothelioma 6 Melanoma 6 Brain Neoplasms 6 NSCLC 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms by Site 4 Lung Diseases 4 Carcinoma, Bronchogenic 4 Advanced Solid Tumors 4 Thoracic Neoplasms 3 Small Cell Lung Carcinoma 3 Respiratory Tract Neoplasms 3 Rectal Neoplasms 3 Neoplasms by Histologic Type 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Bronchial Neoplasms 3

Interventions

pembrolizumab 1 osimertinib 1 binimetinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695925 2025-10-15

TOP

Sun Yat-sen University

Phase 3 Active not recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡